Control of HIV after Antiretroviral Medication Pause (CHAMP)

  • Principal Investigator(s): Jonathan Li
  • Study Contact: Jonathan Li, jli@bwh.harvard.edu
  • Description of Subjects: Post-treatment controllers
  • Location (Domestic vs. International): United States, Canada
  • Enrollment Period: n/a
  • Enrollment Goal: 200
  • Key Exclusion and Inclusion Criteria: Discontinued antiretroviral therapy with viral loads <=400 HIV-1 RNA copies/mL at 2/3 of time points for at least 24 weeks
  • Available Biological Specimens: 
    • Blood, serum, or plasma
    • DNA
    • Peripheral Blood Mononuclear Cells
  • How to Request Access: Email study contact
  • Available Data Description: Clinical and immunological data
  • Optional Additional Comments: If "Elite" is removed from the "Elite Controllers" Keyword, then it would apply to this study.
See also: Blood, serum, and plasma, DNA, HIV+, Brigham and Women's Hospital, Studies < 1000 Participants, Studies Started Post-2005, Domestic, International, Jonathan Li